These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12238917)

  • 1. A new, potent urotensin II receptor peptide agonist containing a Pen residue at the disulfide bridge.
    Grieco P; Carotenuto A; Campiglia P; Zampelli E; Patacchini R; Maggi CA; Novellino E; Rovero P
    J Med Chem; 2002 Sep; 45(20):4391-4. PubMed ID: 12238917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disulfide cyclized tripeptide analogues of angiotensin IV as potent and selective inhibitors of insulin-regulated aminopeptidase (IRAP).
    Andersson H; Demaegdt H; Vauquelin G; Lindeberg G; Karlén A; Hallberg M; Erdélyi M; Hallberg A
    J Med Chem; 2010 Nov; 53(22):8059-71. PubMed ID: 21047126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide.
    Grieco P; Carotenuto A; Campiglia P; Gomez-Monterrey I; Auriemma L; Sala M; Marcozzi C; d'Emmanuele di Villa Bianca R; Brancaccio D; Rovero P; Santicioli P; Meini S; Maggi CA; Novellino E
    J Med Chem; 2009 Jul; 52(13):3927-40. PubMed ID: 19432421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urotensin-II receptor ligands. From agonist to antagonist activity.
    Grieco P; Carotenuto A; Campiglia P; Marinelli L; Lama T; Patacchini R; Santicioli P; Maggi CA; Rovero P; Novellino E
    J Med Chem; 2005 Nov; 48(23):7290-7. PubMed ID: 16279788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel sst5-selective somatostatin dicarba-analogues: synthesis and conformation-affinity relationships.
    D'Addona D; Carotenuto A; Novellino E; Piccand V; Reubi JC; Di Cianni A; Gori F; Papini AM; Ginanneschi M
    J Med Chem; 2008 Feb; 51(3):512-20. PubMed ID: 18210999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
    Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffolds.
    Tamamura H; Araki T; Ueda S; Wang Z; Oishi S; Esaka A; Trent JO; Nakashima H; Yamamoto N; Peiper SC; Otaka A; Fujii N
    J Med Chem; 2005 May; 48(9):3280-9. PubMed ID: 15857134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of residues 3 and 4 in cyclic tetrapeptide ligand recognition by the kappa-opioid receptor.
    Przydzial MJ; Pogozheva ID; Bosse KE; Andrews SM; Tharp TA; Traynor JR; Mosberg HI
    J Pept Res; 2005 Mar; 65(3):333-42. PubMed ID: 15787963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
    Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
    J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution stability of linear vs. cyclic RGD peptides.
    Bogdanowich-Knipp SJ; Chakrabarti S; Williams TD; Dillman RK; Siahaan TJ
    J Pept Res; 1999 May; 53(5):530-41. PubMed ID: 10424348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly potent cyclic disulfide antagonists of somatostatin.
    Hocart SJ; Jain R; Murphy WA; Taylor JE; Coy DH
    J Med Chem; 1999 Jun; 42(11):1863-71. PubMed ID: 10354394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
    Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
    J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human somatostatin receptor specificity of backbone-cyclic analogues containing novel sulfur building units.
    Gazal S; Gelerman G; Ziv O; Karpov O; Litman P; Bracha M; Afargan M; Gilon C
    J Med Chem; 2002 Apr; 45(8):1665-71. PubMed ID: 11931620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological activities of four angiotensin II receptor ligands with gamma-turn mimetics replacing amino acid residues 3-5.
    Schmidt B; Lindman S; Tong W; Lindeberg G; Gogoll A; Lai Z; Thörnwall M; Synnergren B; Nilsson A; Welch CJ; Sohtell M; Westerlund C; Nyberg F; Karlén A; Hallberg A
    J Med Chem; 1997 Mar; 40(6):903-19. PubMed ID: 9083479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide.
    Carotenuto A; Auriemma L; Merlino F; Limatola A; Campiglia P; Gomez-Monterrey I; di Villa Bianca Rd; Brancaccio D; Santicioli P; Meini S; Maggi CA; Novellino E; Grieco P
    J Pept Sci; 2013 May; 19(5):293-300. PubMed ID: 23526702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ring size of somatostatin analogues (ODT-8) modulates receptor selectivity and binding affinity.
    Erchegyi J; Grace CR; Samant M; Cescato R; Piccand V; Riek R; Reubi JC; Rivier JE
    J Med Chem; 2008 May; 51(9):2668-75. PubMed ID: 18410084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential.
    Lewis I; Bauer W; Albert R; Chandramouli N; Pless J; Weckbecker G; Bruns C
    J Med Chem; 2003 Jun; 46(12):2334-44. PubMed ID: 12773038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of peptide disulfide regioisomer formation by mixed cysteine-penicillamine bridges. Application to endothelin-1.
    Hunt JT; Lee VG; Liu EC; Moreland S; McMullen D; Webb ML; Bolgar M
    Int J Pept Protein Res; 1993 Sep; 42(3):249-58. PubMed ID: 8225780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems.
    Behm DJ; Stankus G; Doe CP; Willette RN; Sarau HM; Foley JJ; Schmidt DB; Nuthulaganti P; Fornwald JA; Ames RS; Lambert DG; Calo' G; Camarda V; Aiyar NV; Douglas SA
    Br J Pharmacol; 2006 May; 148(2):173-90. PubMed ID: 16547525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.